Antworten zu den Fragen zur Rheumatoiden Arthritis aus PRAXIS Nr. 23

Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Adrian Ciurea(University of Zurich), V Kaplan

Praxis

December 1, 2008

10.1024/1661-8157.97.24.1309

Cited by 0

Related Papers

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

|Nature Reviews Gastroenterology & Hepatology|2020|2.5k

2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

|Annals of the Rheumatic Diseases|2017|1.6k

Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

|Nature Reviews Gastroenterology & Hepatology|2016|1.4k

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

|Journal of Hepatology|2021|309

Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index

|Liver International|2016|276